Venlafaxine Extended-Release Tablets, 150mg, Rx only, 90 Tablets, Manufactured by Appco Pharma. LLC, NDC 43598-943-90.

FDA recall notice · announced January 29, 2025 · Appco Pharma

Class III FDA/FSIS Class III: use is not likely to cause adverse health consequences.

The product

Venlafaxine Extended-Release Tablets, 150mg, Rx only, 90 Tablets, Manufactured by Appco Pharma. LLC, NDC 43598-943-90.

Reason for recall

Failed Tablet/Capsule Specifications: Missing tab ID on either side of the tablet

Notes

Distribution: Nationwide USA.
Lot/code information: Lot #: 2402101UR, Exp 02/28/2027
Quantity: 1380 bottles
Status: Completed
Products in this recall event:
- Venlafaxine Extended-Release Tablets, 150mg, Rx only, 90 Tablets, Manufactured by Appco Pharma. LLC, NDC 43598-943-90. (D-0208-2025)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.